MedPath

Actigraphic Measurement of a Neurosurgical Procedure

Not Applicable
Completed
Conditions
Sleep Disorders
Circadian Rhythm
Pain
Rehabilitation
Mood Lability
Interventions
Procedure: Re-section of a large left anterior cranial fossa meningioma
Registration Number
NCT00945230
Lead Sponsor
Child Psychopharmacology Institute
Brief Summary

The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.

Detailed Description

Actigraphic measurements, repeated verbal fluency and multi-symptom operationally defined observations will be recorded for an 11 to 12 day baseline period and continued following neurosurgical tumor resection until a repeat MRI is completed three months after the procedure.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1
Inclusion Criteria
  • Diagnosis of incidental meningioma
  • Single subject preparing to receive neurosurgical intervention
Exclusion Criteria
  • Inability to wear actigraphy device

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Actigraphic Neurosurgical OutcomesRe-section of a large left anterior cranial fossa meningiomaActigraphic measurements that will be obtained by attaching the actigraphic watch device to the individual's non-dominant wrist and operationally defined repeated observational measurements. All measurements will continue through a baseline period and continue through the identified post surgical period. Actigraphic measurements will occur every 30 seconds with brief periods of non-measurement during the actual neurosurgical procedure and periods when the actigraphic device has reached storage capacity (approximately every 22 days) when data is retrieved and the device prepared resume measurements.
Primary Outcome Measures
NameTimeMethod
Pre and Post Actigraphic and Systematic Observation Scale measurementsMarch 15, 2009-June 20, 2009
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Child Psychopharmacology Institute

🇺🇸

Fargo, North Dakota, United States

© Copyright 2025. All Rights Reserved by MedPath